ALISON WALD: Open Payments
NPI 1538714555 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,767 in 64 payments from 12 companies in 2025. Trend: 2023 $365 · 2024 $1,067 · 2025 $1,767
Food & beverage: $1,767
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $515 |
| GENZYME CORPORATION | 16 | $359 |
| CSL Behring | 5 | $238 |
| GlaxoSmithKline, LLC. | 10 | $172 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $156 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Organon LLC | 3 | $46 |
| BioCryst US Sales Co., LLC | 1 | $36 |
Products named: TEZSPIRE, DUPIXENT, NEFFY, Andembry, NUCALA, AIRSUPRA, Haegarda, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
